FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2471767903> ?p ?o ?g. }

• W2471767903 endingPage "73" @default.
• W2471767903 startingPage "767" @default.
• W2471767903 abstract "This study was purposed to investigate the engraftment, graft-versus-host disease (GVHD), transplantation related mortality (TRM), relapse and survival in hematologic patients received unrelated umbilical cord blood transplantation (UCBT). A total of 25 patients with hematological disease underwent UCBT, including 8 pediatric and 17 young adult patients. Among them 3 cases received single unit of UCBT and 22 cases received double units of UCBT. For donor/recipients human leukocyte antigen (HLA) matching: HLA 6/6 loci matched in 9 cases, HLA 4-5/6 loci matched in 16 cases. There were 19 patients with hematologic malignancies, including 3 cases in the period of disease progression and 6 cases of non-hematologic malignancies. Conditioning regimens were TBI/Cy ± Flu ± ATG or BuCy ± Flu ± ATG for 21 patients and Cy+Flu+ATG for 4 patients. For prophylaxis of acute graft-versus-host disease (aGVHD) the regimen of cyclosporine (CsA) as dominant drug was used. The results showed that among 16 patients (80.0%) achieved engraftment, 20 patients survived for more than 42 d after transplantation. The cumulative neutrophil recovery rate on day 42 after transplant was 64.0%, with a median time of 17.0 d;the cumulative platelet recovery rate on day 100 after transplant was 60.0 %, with a median time of 35.0 d. The cumulative rate of grade II-IV and III-IV aGVHD after transplantation 100 d was 44.0% and 30.7%, respectively. Until the end of the follow-up, the cumulative rate of TRM was 54.3%. For all the patients, overall survival rate was 42.7%. Out of 17 evaluable patients with hematologic malignancies 7 cases (41.2%) survived to date, and only 1 case relapsed, so event-free survival rate was 35.3%. Out of 5 evaluable patients with non-hematologic malignancies, 4 patients survived and 2 patients were in stable engraftment state, 2 cases with autologous hematopoietic recovery. Among 3 cases of hematologic malignancies at advanced stage, only 1 case survived to date. It is concluded that HLA-4-6/6 loci matched UCBT is an effective option to treat hematological diseases. Double cord blood transplantation (dUCBT) can overcome the disadvantage of insufficient cells of single cord blood UCBT to treat overweight children and adult." @default.
• W2471767903 created "2016-07-22" @default.
• W2471767903 creator A5000797717 @default.
• W2471767903 creator A5002714862 @default.
• W2471767903 creator A5004456765 @default.
• W2471767903 creator A5006739024 @default.
• W2471767903 creator A5018863416 @default.
• W2471767903 creator A5030108757 @default.
• W2471767903 creator A5039848906 @default.
• W2471767903 creator A5042738694 @default.
• W2471767903 creator A5042921774 @default.
• W2471767903 creator A5050723744 @default.
• W2471767903 creator A5051994266 @default.
• W2471767903 creator A5054773838 @default.
• W2471767903 creator A5067241526 @default.
• W2471767903 creator A5068299759 @default.
• W2471767903 creator A5071443000 @default.
• W2471767903 creator A5076694732 @default.
• W2471767903 creator A5079666907 @default.
• W2471767903 date "2014-06-01" @default.
• W2471767903 modified "2023-09-22" @default.
• W2471767903 title "[Clinical study of unrelated umbilical cord blood transplantation for 25 patients with hematological diseases]." @default.
• W2471767903 doi "https://doi.org/10.7534/j.issn.1009-2137.2014.03.036" @default.
• W2471767903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24989292" @default.
• W2471767903 hasPublicationYear "2014" @default.
• W2471767903 type Work @default.
• W2471767903 sameAs 2471767903 @default.
• W2471767903 citedByCount "0" @default.
• W2471767903 crossrefType "journal-article" @default.
• W2471767903 hasAuthorship W2471767903A5000797717 @default.
• W2471767903 hasAuthorship W2471767903A5002714862 @default.
• W2471767903 hasAuthorship W2471767903A5004456765 @default.
• W2471767903 hasAuthorship W2471767903A5006739024 @default.
• W2471767903 hasAuthorship W2471767903A5018863416 @default.
• W2471767903 hasAuthorship W2471767903A5030108757 @default.
• W2471767903 hasAuthorship W2471767903A5039848906 @default.
• W2471767903 hasAuthorship W2471767903A5042738694 @default.
• W2471767903 hasAuthorship W2471767903A5042921774 @default.
• W2471767903 hasAuthorship W2471767903A5050723744 @default.
• W2471767903 hasAuthorship W2471767903A5051994266 @default.
• W2471767903 hasAuthorship W2471767903A5054773838 @default.
• W2471767903 hasAuthorship W2471767903A5067241526 @default.
• W2471767903 hasAuthorship W2471767903A5068299759 @default.
• W2471767903 hasAuthorship W2471767903A5071443000 @default.
• W2471767903 hasAuthorship W2471767903A5076694732 @default.
• W2471767903 hasAuthorship W2471767903A5079666907 @default.
• W2471767903 hasConcept C126322002 @default.
• W2471767903 hasConcept C141071460 @default.
• W2471767903 hasConcept C194409129 @default.
• W2471767903 hasConcept C203014093 @default.
• W2471767903 hasConcept C2776694085 @default.
• W2471767903 hasConcept C2776755627 @default.
• W2471767903 hasConcept C2776955114 @default.
• W2471767903 hasConcept C2777408962 @default.
• W2471767903 hasConcept C2778880498 @default.
• W2471767903 hasConcept C2779972918 @default.
• W2471767903 hasConcept C2908824208 @default.
• W2471767903 hasConcept C2911091166 @default.
• W2471767903 hasConcept C71924100 @default.
• W2471767903 hasConcept C88879693 @default.
• W2471767903 hasConcept C90924648 @default.
• W2471767903 hasConceptScore W2471767903C126322002 @default.
• W2471767903 hasConceptScore W2471767903C141071460 @default.
• W2471767903 hasConceptScore W2471767903C194409129 @default.
• W2471767903 hasConceptScore W2471767903C203014093 @default.
• W2471767903 hasConceptScore W2471767903C2776694085 @default.
• W2471767903 hasConceptScore W2471767903C2776755627 @default.
• W2471767903 hasConceptScore W2471767903C2776955114 @default.
• W2471767903 hasConceptScore W2471767903C2777408962 @default.
• W2471767903 hasConceptScore W2471767903C2778880498 @default.
• W2471767903 hasConceptScore W2471767903C2779972918 @default.
• W2471767903 hasConceptScore W2471767903C2908824208 @default.
• W2471767903 hasConceptScore W2471767903C2911091166 @default.
• W2471767903 hasConceptScore W2471767903C71924100 @default.
• W2471767903 hasConceptScore W2471767903C88879693 @default.
• W2471767903 hasConceptScore W2471767903C90924648 @default.
• W2471767903 hasIssue "3" @default.
• W2471767903 hasLocation W24717679031 @default.
• W2471767903 hasOpenAccess W2471767903 @default.
• W2471767903 hasPrimaryLocation W24717679031 @default.
• W2471767903 hasRelatedWork W2099847697 @default.
• W2471767903 hasRelatedWork W2121876275 @default.
• W2471767903 hasRelatedWork W2187326722 @default.
• W2471767903 hasRelatedWork W2365848850 @default.
• W2471767903 hasRelatedWork W2471767903 @default.
• W2471767903 hasRelatedWork W2558365110 @default.
• W2471767903 hasRelatedWork W2589532264 @default.
• W2471767903 hasRelatedWork W2591816604 @default.
• W2471767903 hasRelatedWork W265735815 @default.
• W2471767903 hasRelatedWork W2903557808 @default.
• W2471767903 hasVolume "22" @default.
• W2471767903 isParatext "false" @default.
• W2471767903 isRetracted "false" @default.
• W2471767903 magId "2471767903" @default.
• W2471767903 workType "article" @default.